课题基金 / 基金详情

Synthesis and neuroprotection of endogenous brain amine, tetrahydroisoquinoline derivatives for experimental parkinson 's animals

Synthesis and neuroprotection of endogenous brain amine, tetrahydroisoquinoline derivatives for experimental parkinson 's animals
内源性脑胺、四氢异喹啉衍生物的合成及其对实验性帕金森病动物的神经保护作用
批准号:
13672301
负责人:
TAGUCHI Kyoji
金额:
$2.18万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2001
资助国家:
日本
项目状态:
已结题
起止时间:
2001 至 2002

项目摘要

项目成果

TAGUCHI Kyoji的其他基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
We carried out behavioral, pathological and biochemical studies in C57BL/6N mice in order to determine whether the stereo-structure of 1-methyl-1,2,3,4-tetrahydroisoquinoline (1-MeTIQ), an endogenous amine present as a mixture of (R)- and (S)-enantiomers, affects the onset of Parkinson's disease-like symptoms, which are induced by 1,2,3,4-tetrahydroisoquinoline (TIQ) in mice. An improved synthesis of (R)- and (S)-1-MeTIQ was achieved via the acid induced Pummere-type cyclization of chiral N-[1-methyl-2- (phenylsulfinyl)ethyl]-N-(1-phenylethyl)formamid as a key step, starting from commercially available (R)- and (S)-benzylamine required 6 steps in about 48% total yield. 1-benzyl-1,2,3,4- tetrahydroisoquinoline (1-BnTIQ) was prepared from benzophenone in 7 steps using Pummere-type cyclization in 55% total yield. These results demonstrated that the Pummere-type cyclization of sulfoxide provides a efficient method of synthesizing of various substituted TIQs. (R)-1-MeTIQ, and not (S)- enant … More iomer, plays a crucial role in the protection of TIQ-induced parkinsonism, a fact which suggests that enantiomeric biochemical events such as 1-MeTIQ biosynthesis may participate in the pathogenesis of PD. TIQ analogs profoundly stimulated dopamine release which resulted in the competitive inhibition of the binding of [11C]raclopride to dopamine D2 receptors, but did not induce degeneration of the receptors. Next, we administered 1-BnTIQ, an endogenous neurotoxin known to cause bradykinesia, the Parkinson's disease-like symptoms, in order to obtain biochemical and pathological evidence of behavioral abnormalities. 1-BnTIQ-induced bradykinesia has a different mechanism of action than that underlying the MPTP-induced depletion of striatal DA neurons, that 1-BnTIQ does not affect the density of DATs on dopaminergic neurons. TIQ-induced parkinsonism model is different from the MPTP-induced model as evaluated by the radioligand-DATs binding and that (S)- 1-MeTIQ has a preventing effect for the degeneration of the DATs to a certain extent. Less
期刊论文(5)
专著(0)
科研奖励(0)
会议论文
Kiichi Ishikawa, Yasuhiro Koyanagi, Kenji Abe, Kazunori Kawamura,Kyoji Taguchi, Toshiaki Saitoh, Jun Toda and Takehiro Sano.: "Effects of single and repeated administration of 1,2,3,4-tetrahydroisoquinoline analogs on the binding of [11C]racloprode to dop
Kiichi Ishikawa、Yasuhiro Koyanagi、Kenji Abe、Kazunori Kawamura、Kyoji Taguchi、Toshiaki Saitoh、Jun Toda 和 Takehiro Sano.:“单次和重复施用 1,2,3,4-四氢异喹啉类似物对 [11C] 结合的影响
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Kiichi Ishikawa et al.: "Effects of single and repeated administration of 1,2,3,4-tetrahydroisoquinoline analogs on the binding of [11C]racloprode to dopamine D2 receptors in the mouse brain"Journal of Neuronal Transmission. 108. 1111-1125 (2001)
Kiichi Ishikawa 等人:“单次和重复施用 1,2,3,4-四氢异喹啉类似物对 [11C]雷氯普罗德与小鼠大脑中多巴胺 D2 受体结合的影响”神经传递杂志。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Kiichi Ishiwata et al.: "No reduction of dopamine transporter binding sites in mice following treatment with the TIQ analogue 1-benzyl-1,2,3,4-tetrahydroisoquinoline"Brain Research. 960. 282-285 (2003)
Kiichi Ishiwata 等人:“用 TIQ 类似物 1-苄基-1,2,3,4-四氢异喹啉治疗后,小鼠多巴胺转运蛋白结合位点没有减少”大脑研究。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Kenji Abe, Kyoji Taguchi, Tomoko Wasai, Jin Ren, Iku Utsunomiya,Tatsumi Shinohara, Tadashi Miyatake and Takehiro Sano.: "Biochemical and pathological study of endogenous 1 - benzyl - 1,2,3,4 -tetrahydroisoquinoline -induced parkinsonism in the mouse."Brai
Kenji Abe、Kyoji Taguchi、Tomoko Wasai、Jin Ren、Iku Utsunomiya、Tatsumi Shinohara、Tadashi Miyatake 和 Takehiro Sano.:“内源性 1 - 苄基 - 1,2,3,4 -四氢异喹啉诱发的帕金森症的生化和病理学研究
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Neurophysiological and immunohistochemical studies of IgG anti-GM1 monoclonal antibody on neuromuscular transmission
  • 批准号:
    22590087
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 资助金额:
    $1.08万
  • 财政年份:
    2010
  • 负责人:
    TAGUCHI Kyoji
  • 依托单位: